Skip to main content
Intercure Ltd. logo

Intercure Ltd. — Investor Relations & Filings

Ticker · INCR ISIN · IL0011063760 LEI · 549300KI5ESXF8F5GP06 TA Manufacturing
Open in API
Filings indexed 334 across all filing types
Latest filing 2022-05-16 Report Publication Anno…
Country IL Israel
Listing TA INCR

About Intercure Ltd.

https://www.intercure.co

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Recent filings

Filing Released Lang Actions
to Release its Q1 2022 Results and Hold a Conference Call on May 17, 2022
Report Publication Announcement Classification · 1% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. It explicitly states, 'Attached hereto is a report on *Q122_Webcast_isa.pdf*'. This structure—a brief regulatory filing announcing the availability of an attached document (likely a webcast transcript or presentation related to Q1 2022 results)—fits the definition of a Report Publication Announcement (RPA). The document length is very short (1799 chars), reinforcing the 'MENU VS MEAL' rule, which suggests classifying it as the announcement rather than the full report itself (like CT or ER). Since it announces the publication of a specific report/webcast, RPA is the most appropriate code.
2022-05-16 English
InterCure to Participate in Upcoming Investor Conferences in May 2022
Report Publication Announcement Classification · 1% confidence The document is a press release from InterCure Ltd. announcing that its CEO and CFO will participate in upcoming investor conferences in May 2022 (Canaccord Genuity and Cowen conferences). This type of announcement, which details management's schedule for meeting with investors at industry events, is best classified as an Investor Presentation (IP) or related investor relations activity. Since there is no specific category for 'Investor Conference Participation Announcement,' and it is not a formal regulatory filing, earnings release, or dividend notice, it falls under general investor communication. However, given the context of management actively engaging with investors at conferences, it is closely related to Investor Presentation (IP) materials, but more accurately, it is a general announcement about investor engagement. Reviewing the definitions, 'Investor Presentation (IP)' is for detailed presentations. This document is an announcement about management availability for meetings. Since it is a direct communication to investors about management's schedule, and it is not a formal report, the closest fit among the provided options that relates to investor engagement outside of formal reporting is often grouped with investor-facing materials. Given the options, and recognizing this is a standard IR announcement, it is most similar in intent to an Investor Presentation (IP) or a general Regulatory Filing (RNS). Since it is a specific announcement about management meeting investors, and not a general regulatory filing, I will check if there is a better fit. None of the other codes fit well (e.g., not ER, not DIV, not 10-K). In many databases, such announcements are categorized under Investor Relations/Presentations. I will classify this as an Investor Presentation (IP) as it pertains to management's direct engagement strategy with investors, although it is technically an announcement of participation rather than the presentation itself. If 'RNS' were used as a catch-all, it would fit, but 'IP' captures the subject matter better.
2022-05-09 English
InterCure to Participate in Upcoming Investor Conferences in May 2022
Report Publication Announcement Classification · 1% confidence The document is a short filing (1807 chars) from INTERCURE LTD, reporting to the Israel Securities Authority and the Tel Aviv Stock Exchange. It is titled 'Immediate Report' under 'Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000'. Crucially, the text states: 'Attached hereto is a report on *Investor_Conferences_isa.pdf*'. This structure—a brief announcement stating that a specific report is attached or published—fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. It is not the full content of the investor conference report itself.
2022-05-09 English
InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference
Regulatory Filings Classification · 1% confidence The document text is a press release dated May 3, 2022, announcing that the CEO of InterCure will participate in the 'A.G.P.'s Spring Consumer Cannabis Conference'. This is an announcement about executive participation in an industry event, not the presentation materials themselves, a transcript, or a formal regulatory filing like a 10-K or ER. Since there is no specific category for 'Executive Conference Participation Announcement', and the event is an 'A.G.P.'s Spring Consumer Cannabis Conference' (which is a type of investor/industry event), the closest fit among the provided options is 'AGM Information' (AGM-R) if interpreted broadly as 'Investor/Shareholder Meeting Related Information', or more appropriately, 'Regulatory Filings' (RNS) as a general announcement. However, given the context of investor relations announcements, and the fact that it is an announcement about participation in a conference, it is a general corporate communication. Since it is not a formal report, transcript, or specific financial filing, RNS is the most appropriate fallback for a general corporate announcement that doesn't fit the other specific categories like ER or CT. Upon re-evaluation, this is a standard press release announcing executive participation in a conference, which is a common type of investor relations communication. It does not fit AGM-R (which is for AGM materials), ER (which is for financial results), or IP (which is an investor presentation). Therefore, RNS (Regulatory Filings/General Announcement) is the correct fallback.
2022-05-03 English
InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference
Report Publication Announcement Classification · 1% confidence The document is a short regulatory filing (1824 characters) submitted to the Israel Securities Authority and the Tel Aviv Stock Exchange. It is titled 'Immediate Report' under Regulation 4 for a 'Foreign Corporation'. Crucially, the text states: 'Attached hereto is a report on* Spring_Consumer_Cannabis_Conference_isa.pdf'. This indicates the document itself is merely an announcement that another report (likely a presentation or transcript related to a conference) is attached or linked, rather than being the full content of that report. According to Rule 2, when a document is short and announces the publication of another report, it should be classified as a Report Publication Announcement (RPA).
2022-05-03 English
Annual Report 2021
Annual Report FY 2021
2022-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.